ANXA2 and breast carcinoma: Interestingly, Seckinger's group demonstrated that annexin A2 expression in primary myeloma cells is an adverse prognostic factor 41 and an increased expression of annexin A2 has been also reported as a poor prognostic factor for solid tumours such as pancreatic and breast cancer 42, 43.